WALTHAM, Mass., June 07, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO ), an oncology-focused biopharmaceutical company, today announced its participation at the Goldman Sachs 38th Annual Global Healthcare Conference, to be held June 13-15, 2017 at the Terranea Resort in Rancho Palos Verdes, California. Tim Pearson, EVP and CFO of TESARO, will present at 10:40 AM PT on June 15 and will participate in meetings with investors.
A live webcast of the presentation will be available by visiting the Investors section of the TESARO website at www.tesarobio.com . An archived replay of this webcast will be available on the Company’s website for 14 days following the conferences.
About TESARO TESARO is an oncology-focused biopharmaceutical company devoted to providing transformative therapies to people bravely facing cancer. For more information, visit www.tesarobio.com , and follow us on Twitter and LinkedIn .
For additional information, please contact: Jennifer Davis 1.781.325.1116 jdavis@tesarobio.com